- PRP injections showed greater improvement in sexual function for postmenopausal vulvovaginal atrophy.
- All patients who received PRP had previously undergone estrogen therapy without adequate response.
- FSFI scores were significantly higher in the PRP group at week 12 compared to the estrogen group.
- No acute adverse effects were reported for PRP injections.
- Authors highlighted small sample size and lack of assessment for partner sexual dysfunction as study limitations.
Source: Frontiers
